Paroxetine mesylate 7.5 MG Oral Capsule [Brisdelle] — RxCUI 1430128
RxNorm drug concept · Semantic branded drug
RxCUI 1430128
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1430128
Official nameParoxetine mesylate 7.5 MG Oral Capsule [Brisdelle]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBrisdelle 7.5 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Paroxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It usually takes a few weeks before you notice the full benefit — that's completely normal for this type of medication. Some people notice small improvements in sleep or energy wit...
- How long before I start feeling better on paroxetine?
- Please don't stop suddenly — paroxetine is one of the antidepressants most likely to cause discontinuation symptoms if you quit cold turkey. These can include dizziness, nausea, ir...
- Can I just stop taking paroxetine if I feel better or if it bothers me?
🕸️ Concept Web — How Paroxetine mesylate 7.5 MG Oral Capsule [Brisdel... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Paroxetine mesylate 7.5 MG Oral Capsule [Brisdelle]
RxCUI 1430128 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Paroxetine
32937IN -
Paroxetine mesylate
436212PIN
-
Paroxetine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Brisdelle
1430123BN
-
Brisdelle
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Paroxetine Oral Capsule
1430121SCDF -
Paroxetine mesylate Oral Capsule
2647063SCDFP -
Paroxetine Oral Product
1164137SCDG -
Paroxetine Pill
1164138SCDG -
Paroxetine mesylate Oral Product
2661790SCDGP -
Paroxetine mesylate Pill
2660048SCDGP -
Paroxetine Oral Capsule [Brisdelle]
1430125SBDF -
Paroxetine mesylate Oral Capsule [Brisdelle]
2657780SBDFP - +5 more in this family
-
Paroxetine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Paroxetine mesylate 7.5 MG Oral Capsule
1430122SCD -
Paroxetine mesylate 7.5 MG
1738562SCDC -
Paroxetine mesylate 7.5 MG [Brisdelle]
1738564SBDC
-
Paroxetine mesylate 7.5 MG Oral Capsule
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Paroxetine mesylate 7.5 MG Oral Capsule
SCD · 1430122 -
Paroxetine mesylate 7.5 MG
SCDC · 1738562 -
Paroxetine Oral Capsule
SCDF · 1430121 -
Paroxetine mesylate Oral Capsule
SCDFP · 2647063 -
Paroxetine Oral Product
SCDG · 1164137 -
Paroxetine Pill
SCDG · 1164138 -
Paroxetine mesylate Oral Product
SCDGP · 2661790 -
Paroxetine mesylate Pill
SCDGP · 2660048
Brand-Name Concepts
-
Paroxetine mesylate 7.5 MG [Brisdelle]
SBDC · 1738564 -
Paroxetine Oral Capsule [Brisdelle]
SBDF · 1430125 -
Paroxetine mesylate Oral Capsule [Brisdelle]
SBDFP · 2657780 -
Brisdelle Oral Product
SBDG · 1430126 -
Brisdelle Pill
SBDG · 1430127 -
Brisdelle
BN · 1430123
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1430128 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 83107-0027-30 | 30 CAPSULE in 1 BLISTER PACK (83107-027-30) | BRISDELLE | Legacy Pharma USA, Inc. | 2025-02-18 |
Observed labelers:
Legacy Pharma USA, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.